Illumina Inc. (ILMN) fell back 7.8% in premarket trading Monday after Roche Holding (RHHBY) Chairman Franz Humer said in an interview that the company doesn't plan to buy the gene sequencing specialist.

"Illumina is definitely off the table," Humer said in an interview published Sunday. Shares of Illumina fell to $50.50 in recent premarket trading. Roche had approached Illumina with a buyout offer of $6.8 billion last year, but the company was rebuffed.

-Write to Steve Gelsi at sgelsi@marketwatch.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Illumina Charts.
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Illumina Charts.